Indane derivatives
AssigneeAventis Pharma S.A.
InventorsGarry Fenton, Clive McCarthy, Robert Edward Mackenzie, Andrew David Morley
Life of this patent
Estimating the term…
Loading patent…
AssigneeAventis Pharma S.A.
InventorsGarry Fenton, Clive McCarthy, Robert Edward Mackenzie, Andrew David Morley
Estimating the term…
The invention is directed to physiologically active compounds of general formula (I): 1 wherein: R1 represents aryl, heteroaryl or a group R3-L2-Ar1-L3-; R2 represents hydrogen or lower alkyl; R3 represents aryl or heteroaryl; and Ar1 represents an optionally substituted saturated, partially saturated or fully unsaturated 8 to 10 membered bicyclic ring system containing at least one heteroatom selected from O, S or N; Y is carboxy or an acid bioisostere; and their corresponding N-oxides or prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their corresponding N-oxides or prodrugs. Such compounds have valuable pharmaceutical properties, in particular the ability to regulate the interaction of VCAM-1 and fibronectin with the integrin VLA-4 (α4β1).
A compound of general formula (I):
Dependencies are inferred from the claim text.